From production to bedside: A tiered QC framework for regulatory alignment and analytical comparability in decentralized CGT
{{output}}
Decentralized and point-of-care (PoC) manufacturing is reshaping cell and gene therapy (CGT) by bringing production closer to patients. This model offers advantages, including reduced vein-to-vein times, streamlined logistics, and greater flexibility for patie... ...